Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/10/worx-stock-slides-as-nasdaq-relisting-and-financing-raise-questions.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

WORX Stock Slides As Nasdaq Relisting And Financing Raise Questions

TIM BOHEN•UPDATED OCT. 13, 2026, 7:47 AM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

SCWorx Corp. faces intensified investor uncertainty after critical financial compliance news, and its stocks have been trading down by -16.77 percent.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading WORX

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

  • SCWorx stock fell 17% in premarket trading, extending an 11.2% loss from the prior Friday close.
  • Nasdaq approved the reinstatement of trading in SCWorx common stock, with shares scheduled to resume trading on the Nasdaq Capital Market on 2026/10/07.
  • SCWorx raised about $938,000 in a private equity financing by selling 350,000 common shares plus five‑year warrants to institutional and accredited traders.
  • The new capital is intended to help SCWorx regain Nasdaq Capital Market compliance, but funds are segregated and can be clawed back if relisting and trading do not hold by late 2026/10.

Candlestick Chart

Live Update At 07:46:53 EDT: On Tuesday, October 13, 2026 SCWorx Corp. stock [NASDAQ: WORX] is trending down by -16.77%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

WORX is trading like a rollercoaster, and the numbers back that up. After stabilizing around the mid‑$2s in late September, WORX exploded to a high of $7.25 on 2026/10/06 before fading back under $4 and then to $3.16 on 2026/10/12. That sharp rise and fall tells traders one thing: this is a thin, volatile stock where sentiment shifts fast and liquidity matters.

On the fundamentals, SCWorx is still a turnaround story. The latest report shows quarterly revenue of about $706,000, but operating income came in at a loss of roughly $121,000. Margins are deeply negative, with profit metrics well below zero, and return on equity and assets both sharply in the red. WORX does, however, have some balance‑sheet breathing room. Cash stands around $1.26M, current assets exceed current liabilities, and the company carries essentially no long‑term debt.

More Breaking News

Valuation ratios paint SCWorx as a beaten‑down microcap. Price‑to‑sales hovers near 1x and price‑to‑book sits well under 1x, the kind of discount traders often associate with distressed or ignored names. For WORX, the key is whether that discount becomes a value trap or a fuel source for the next momentum spike.

Why Traders Are Watching WORX Volatility

WORX is back in the headlines for all the wrong and right reasons at the same time. On one hand, SCWorx just secured Nasdaq approval to reinstate trading on the Nasdaq Capital Market as of 2026/10/07. That is a real milestone for WORX, restoring access to a major exchange, more eyes, and better liquidity. On the other hand, the stock promptly dropped 11.2% on Friday and then another 17% in premarket trading, signaling that traders are selling the news, not celebrating it.

Behind the scenes, SCWorx raised about $938,000 through a private equity deal, issuing 350,000 common shares and five‑year warrants. For WORX, that capital is aimed at working capital and—equally important—at meeting Nasdaq’s listing standards by boosting the public float above 500,000 shares and supporting a $1.00 minimum bid. Traders who track small‑cap compliance stories know this playbook well.

But there is a catch that matters for every WORX chart watcher. Those funds are locked in a segregated account and can be clawed back if Nasdaq relisting and active trading are not maintained by late 2026/10. That means the financing is conditional. If WORX stumbles on compliance, the cash lifeline shrinks.

Combine that overhang with the intraday tape: premarket five‑minute candles show WORX fading from the mid‑$5s and $6s down into the high‑$2s. That kind of intraday range—more than 50% peak‑to‑trough—draws momentum traders, short‑biased traders, and dip‑buyers all to the same battlefield. WORX is not a quiet relisting story; it is a live volatility lab.

Conclusion

For active traders, WORX sits at the intersection of fundamental stress and headline‑driven opportunity. SCWorx has negative earnings, heavy losses on key profitability ratios, and shrinking revenues over the multi‑year view. Yet it still carries over $1.2M in cash, minimal debt, and a Nasdaq relisting approval that gives WORX a platform most microcaps would love to have.

The latest price action tells you how conflicted the market is. WORX ripped from the $3s to above $7, then broke down hard as traders digested dilution from the $938,000 equity raise and the possibility that those funds vanish if listing milestones slip. This is the classic tug‑of‑war: improved access to capital and a national exchange versus execution risk, dilution, and a fragile bid.

For traders who follow the Tim Sykes style of trading, WORX is a case study in preparation and discipline. As Tim Sykes likes to say, “Patterns repeat, but only prepared traders profit from them.” As Tim Bohen, lead trainer with StocksToTrade says, “For me, trading is more about managing risk than finding the next big mover.” WORX is flashing one of those repeat patterns—relisting catalyst, financing, violent moves up and down.

That does not make SCWorx a buy or a sell. It makes WORX a stock to study, to track on the daily and intraday charts, and to approach with a clear plan, tight risk, and zero hesitation to cut losses fast. This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders